Lilly’s trial registry launched
Lilly has launched its online
registry of clinical trials of its products
(PJ, 28 August, p281).
Available at www.lillytrials.com, the registry at present contains nearly
half the data the company has committed to making publicly available.
The company aims to make the remaining data available by July 2005.
For phase I–IV clinical trials of marketed products, the company
will post the predefined primary and secondary outcome measure results,
safety and efficacy results and any results that do not support the hypothesis
or are contrary to the expected outcome. The results will be posted when
a drug’s indication is approved and the drug is commercially available.
Lilly will also make available details of all initiated phase II–IV
trials that it sponsors, including information on the status of the trial
and its projected end date. |
The
Pharmaceutical Journal
Acrobat
Reader